Decided to pay a $75 million good and forfeit $2.

CVS agrees to record fine to settle meth suit The CVS retail pharmacy chain agreed Thursday to pay an archive fine to settle a civil case brought by federal prosecutors who said the business had allowed criminals to buy large amounts of methamphetamine ingredients over the counter viagra-ou-cialis.html . Decided to pay a $75 million good and forfeit $2.6 million in profits on the unlawful sales of pseudoephedrine in California and Nevada in 2007 and 2008, regarding to federal prosecutors based in Los Angeles.

Food and Medication Administration for the look of its new phase III trial of pixantrone for sufferers with relapsed or refractory aggressive B-Cell non-Hodgkin’s lymphoma . In the filing, CTI proposed to the FDA that the randomized study will compare pixantrone plus rituximab against the current standard regimens used to take care of this patient group. This trial is certainly planned to enroll relapsed or refractory aggressive B-Cell NHL sufferers who failed first-line to third-range treatment with standard chemotherapy and are not really transplant eligible. We anticipate a lot of the patients because of this trial will be enrolled in the U.S., said Jack Singer, M.D., Chief Medical Officer at CTI. There are no approved brokers in this setting and no standard of treatment regimens therefore the unmet medical need is notable.

Random entries

Other entries from category "pharmacy news":